General information
    ACovPid:ACoVP100450
    Trivial Name:SARS-CoV-2 HRC
    Amino Acids Sequence:DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL
    Length:36
    C-Terminal Modification:None
    N-Terminal Modification:None
    Chemical Modification:None
    Peptide Source:

    Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049

    Source Description:
    Against Virus:

    Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049

    Inhibition Value Type:IC90
    Inhibitory Effect:0.098 ± 0.057
    Inhibitory Unit:µM
    Target Domain Name:
    Assay:β-Gal complementation-based fusion assay.
    Assay Description:The author previously adapted a fusion assay based on alpha complementation of β-galactosidase (β-Gal). The assay is based on alpha complementation of beta-gal; the beta-gal protein lacking the N-terminal 85 residues (omega peptide) is expressed from one plasmid, and the N-terminal 85 residues (alpha peptide) is expressed from a second plasmid. Cell fusion leads to complementation, and beta-galactosidase is quantitated using the Galacto-Star (Applied Biosystems) chemiluminescent reporter gene assay system. Receptor bearing cells expressing the omega peptide are mixed with viral glycoproteins co-expressing cells that also express the alpha peptide, at various temperatures and at specific time points. Fusion is stopped by lysing the cells with lysis buffer. In this assay, hACE2 or DDP4 receptor-bearing cells expressing the omega peptide of β-Gal are mixed with cells coexpressing glycoprotein S and the alpha peptide of β-Gal, and cell fusion leads to alpha-omega complementation. Fusion is stopped by lysing the cells, and after addition of the substrate (Tropix Galacto-Star chemiluminescent reporter assay system; Applied Biosystem), luminescence is quantified on a Tecan M1000PRO microplate reader.
    Anti-CoV activity in vivo:
    Reference:33082259
    Comment:
    3D structure:

    StructureACoVP100450

    Structure Experiment Verified:NO
    Similar Peptides:ACoVP100119   ACoVP100241   ACoVP100125   ACoVP100389   ACoVP100120